HOSPITAL UNIVERSITARIO RUBER
Departamento
Kliniken Essen-Mitte
Essen, AlemaniaPublicacións en colaboración con investigadores/as de Kliniken Essen-Mitte (3)
2020
-
Pembrolizumab for early triple-negative breast cancer
New England Journal of Medicine, Vol. 382, Núm. 9, pp. 810-821
2019
2018
-
Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial
Journal of Clinical Oncology, Vol. 36, Núm. 31, pp. 3126-3133